Charles River Stock (NYSE: CRL) stock price, news, charts, stock research, profile.
Open | $225.290 |
Close | $221.610 |
Volume / Avg. | 927.644K / 531.260K |
Day Range | 220.370 - 225.290 |
52 Wk Range | 161.650 - 275.000 |
Market Cap | $11.416B |
P/E Ratio | 26.410 |
Dividend Yield | - |
Exchange | NYSE |
RSI | 35 |
Short Interest | 4.79% |
Days to Cover | 3.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Charles River (NYSE: CRL) through any online brokerage.
Other companies in Charles River’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
The latest price target for Charles River (NYSE: CRL) was reported by TD Cowen on Monday, May 13, 2024. The analyst firm set a price target for 228.00 expecting CRL to rise to within 12 months (a possible 2.88% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Charles River (NYSE: CRL) is $221.61 last updated May 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Charles River.
Charles River’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Charles River.
Charles River is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.